
Total Plasma Exchange in a Patient with Progressive Multifocal Leukoencephalopathy (PML) Associated with Natalizumab Therapy
Specialty: | Clinical Laboratory Infectious Diseases Toxicology |
Objective: | |
ICD-10: | |
Description: | Patients with multiple sclerosis (MS) who are treated with natalizumab are at risk for developing Progressive Multifocal Leukoencephalopathy (PML). Immune reconstitution is needed to clear the infection, and the monoclonal antibody can be cleared faster with total plasma exchange. |
To read more or access our algorithms and calculators, please log in or register.